| Name | (1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl) 4-[(4-hydroxy-2-oxochromen-3-yl)methyl]benzoate |
|---|---|
| Synonyms |
tecarfarin
ati-5923 unii-wn1479yt50 |
| Description | Tecarfarin (ATI-5923) is an orally active and non-competitive vitamin K epoxide reductase (VKOR) antagonist, and impairs the activation of the vitamin K-dependent clotting factors II, VII, IX and X[1]. Tecarfarin has the antithrombotic activity [2]. |
|---|---|
| Related Catalog | |
| Target |
VKOR[1] |
| References |
| Molecular Formula | C21H14F6O5 |
|---|---|
| Molecular Weight | 460.32300 |
| Exact Mass | 460.07500 |
| PSA | 76.74000 |
| LogP | 5.12950 |